Innovative and mundane

Belgium’s IRE and SCK-CEN cooperate against prostate cancer

Belgium’s National Institute for Radioelements (IRE) and nuclear research centre SCK-CEN have signed an agreement to join efforts on the production of lutetium-177 (Lu-177), a medical radioisotope mainly used to treat prostate cancer.

In a joint statement the two organisations said the use of Lu-177 is one of the most promising approaches to treating prostate cancer.

Related news